Company · Healthcare
SeQuent Scientific / Viyash Scientific.
PublicTracked across 1 covered firm · 1 equity · 0 creditVintage Sep 2026Healthcare sector dossier →
Equity holders · 1
| Firm | Entered | Entry | Status | 12-mo | Read |
|---|---|---|---|---|---|
| Carlyle | 2020 | 74% control (₹1,500+ Cr) via CA Harbor Investments | Public | ▲ | ₹8,000 Cr merger with Viyash Life Sciences (announced Sep 2024, NCLT-cleared, effective late 2025) built India's largest animal-health platform; Carlyle holds 61.3% of the combined entity |
Aggregated from Gravitywell's tracked position books: covered firms only, not the full cap table. Entries, stages and reads are per-holder reconstructions from public disclosures (E). Point-in-time as of Sep 2026.
Stay ahead